Menu
Biology articles
The Golden Goose Is Awarded
Salmonella Strain Spreads Alongside HIV
Fair Flu Viruses Closely Matched
Creative Emulsification
Inflammation for Regeneration
Editor's choice in microbiology
Debate Over Stem Cell Effectiveness
Editor's choice in molecular biology
Telomeres Affect Gene Expression
Re-sensitizing Resistant Bacteria
Vitamin C Slays TB Bacteria
Plant scientists, innovators
The First Plant Interactome
Plant RNAs Found in Mammals
Opinion: Beyond the Model
Sweet and Sour Science
Plant RNA Paper Questioned
Flower Barcodes
Microbial Perfume
How Plants Feel
New Databases Harvest a Rich Bounty of Information on Crop Plant Metabolism
Carnegie Institution for Science Receives Grand Challenges Explorations Grant
Genetically engineered trees could help restore devastated American chestnut
Evolution coup: study reveals how plants protect their genes
  Vitamin C Slays TB Bacteria
High doses of vitamin C can rapidly wipe out entire populations of drug-resistant strains of the bacteria that cause tuberculosis (TB) by inducing a chemical reaction that produces high levels of DNA-damaging oxidative radicals, according to a study published today (May 21) in Nature Communications.

The study was done on Mycobacterium tuberculosis in lab cultures, but if the results hold up in vivo, it raises the possibility that vitamin C could be added to existing TB drugs to speed up treatment. Moreover, by elucidating the mechanism by which vitamin C kills M. tuberculosis, the work suggests a promising route for the development of new TB drugs to tackle these hard-to-kill bacteria.

“[The research] shows that perhaps M. tuberculosis doesn’t have quite the iron-clad armor that we often associate with it; that is does perhaps have some Achilles heels and weak underbellies,” said William Bishai, director of the KwaZulu-Natal Research Institute for Tuberculosis and HIV in Durban, South Africa, who was not involved in the study.

But Bishai warned that it will be difficult to achieve the high concentrations of vitamin C required in humans, and added that “there is still a little bit more proof of principle needed” before large-scale drug discovery efforts centered around this mechanism can begin. “I think the question would be, can we identify a more potent reductant that would be delivered at lower concentrations but still stimulate the oxidative radicals?"

“We’re not saying vitamin C is the cure for TB,” said Catherine Vilcheze of the Albert Einstein Medical College at Yeshiva University in New York, who was first author on the study. “But we should look at trying to find ways to mimic the way it kills TB bacteria [in vitro], because it is very, very effective.”

The initial discovery of vitamin C’s TB-killing ability came about by accident. To test their hypothesis that the amino acid cysteine helps the TB drug isoniazid (INH) kill off M. tuberculosis by acting as a reductant to produce oxidative radicals, Vilcheze and colleagues decided to see if vitamin C, another reducing agent, would have the same effect. It did. But the researchers were shocked to see that vitamin C alone, used as a control, also wiped out the bacteria. “I was not expecting any effect at all, so that was very surprising,” Vilcheze said.

The researchers then demonstrated that at a certain concentration, vitamin C could sterilize cultures within just a few weeks. It had the same effect on drug resistant strains and extensively-drug-resistant strains. “If you start with about 10 million cells, after 3 weeks [of vitamin C treatment] there is nothing left in your culture,” said Vilcheze. “It kills everything.” Concentrations had to be much higher to achieve that same effect in other pathogens, however, so M. tuberculosis is uniquely susceptible.

The team hypothesized that vitamin C killed the bacteria by driving an iron-dependent reaction that produces reactive oxygen species (ROS), which can induce cell death via DNA damage. Sure enough, when added to the bacteria in an environment that lacked oxygen or was depleted for iron, the vitamin C lost its sterilization capacity. What’s more, levels of ROS and oxidative damage to DNA and lipids in cell walls and membranes were far higher in cultures treated with vitamin C than controls that were either untreated or treated with vitamin E.

The study also demonstrated that vitamin C’s effect was increased 60-fold in M. tuberculosis strains deficient for mycothiol, which protects the cells from oxidative damage. This suggests that a combination therapy pairing a mycothiol inhibitor with vitamin C, or similar compounds that produce an oxidative burst, could potentially kill the pathogen more quickly than available treatments, said Vilcheze.

And although Bishai cautioned that the high concentrations of vitamin C used in the experiment would be hard to replicate in the human body, he added that it might be possible to develop a more potent but equally well-tolerated reductant to do the same job.

In the meantime, study leader Bill Jacobs, also at Albert Einstein Medical College, wants to carry out clinical trials to see if adding vitamin C supplements to current drug regimens could benefit TB patients. “We don’t know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial,” said Jacobs in a press release. “At the very least,” added Jacobs, “this work shows us a new mechanism that we can exploit to attack TB.”
Plants Put Limit on Ice Ages
Carnegie donates landmark clones to biology
Plants on Steroids: Key Missing Link Discovered
Gene Function Discovery: Guilt by Association
Cracking the Plant-Cell Membrane Code
Private Support Helps Public Plant Research
Scientists Watch Cell-Shape Process for First Time
How plants choose their mates
Mastermind Steroid Found in Plants
Unlocking the secrets of a plant’s light sensitivity
Nailing down a crucial plant signaling system
What makes a plant a plant?
New component of a plant steroid-activated pathway discovered
Big Boost to Plant Research
The Heart of the Plant
New tool offers unprecedented access for root studies
Steroids control gas exchange in plants
Plant toughness: Key to cracking biofuels?
Amoeba may offer key clue to photosynthetic evolution
The future of plant science – a technology perspective
Plant research funding crucial for the future
Wolf B. Frommer Receives Bogorad Award for Excellence in Plant Biology
Lighting up the plant hormone “command system”
Plant organ development breakthrough
Breakthrough: How salt stops plant growth
New Cancer Diagnostic Technique Debuts
Plant Science Could Ease Global Food and Fuel Demands
Have you had your cereal today?
Menu
Researchers close in on engineering recognizable, drug-free Cannabis plant
UC Riverside Researchers Develop Genetic Map for Cowpea
New research shows how mobile DNA survives—and thrives—in plants, animals
Cucumber Genome Published
Structural study at EMBL reveals how plants respond to water shortages
“Safety Valve” Protects Photosynthesis from Too Much Light
Weeds Could Help To Feed The World
Antagonistic Genes Control Rice Growth
Making New Enzymes to Engineer Plants for Biofuel Production
Green Plant Transport Mystery Solved
Gene Discovery To Increase Biomass Needed For Green Fuel
Are genes our destiny?
New African cassava resists devastating viruses
Species richness and genetic diversity do not go hand in hand in alpine plants
Scientists discover how cancer may take hold
Green algae—the nexus of plant/animal ancestry
New Twist on Life’s Power Source
Controlling a sea of information
Plant Steroids Offer New Paradigm for How Hormones Work
Future of biology rests in harnessing data avalanche
Carnegie’s Arthur Grossman Receives Gilbert Morgan Smith Medal
Plant Scientists Participate in DOE Energy Frontier Research Center
Advance in understanding cellulose synthesis
Midget Plant Gets Makeover